Replies to post #213077 on Biotech Values

[jq1234]

>> is the extra MC glpg over fgen justifiable?


The difference in MC right now is from cash position. GLPG had almost $1.5B cash at end of 2Q17. Plus 2nd highest valuation for GLPG still comes from CF not IPF, which was why GLPG took a little bit hit after stellar results from VRTX early triple combo data.